Literature DB >> 21460726

Challenges to establishing nationwide diabetic retinopathy screening programs.

Ribhi Hazin1, Mohammed K Barazi, Michael Summerfield.   

Abstract

PURPOSE OF REVIEW: To review the results of recently published studies on diabetic retinopathy screening. RECENT
FINDINGS: Despite numerous public health campaigns and the existence of guidelines designed to promote annual retinal exams for diabetes patients, an unacceptably high number of patients are not screened for diabetic retinopathy. Current findings suggest the need for novel methods to improve compliance with retinal screening exams among diabetes patients to preserve vision functionality in this population.
SUMMARY: Diabetic retinopathy represents a major cause of acquired vision loss. The following review addresses the factors that contribute to inadequate retinopathy screenings among diabetes patients and proposes solutions that have the potential to increase the quality and accessibility of screening programs for diabetes patients.

Entities:  

Mesh:

Year:  2011        PMID: 21460726     DOI: 10.1097/ICU.0b013e32834595e8

Source DB:  PubMed          Journal:  Curr Opin Ophthalmol        ISSN: 1040-8738            Impact factor:   3.761


  10 in total

1.  Utility of hard exudates for the screening of macular edema.

Authors:  Taras V Litvin; Glen Y Ozawa; George H Bresnick; Jorge A Cuadros; Matthew S Muller; Ann E Elsner; Thomas J Gast
Journal:  Optom Vis Sci       Date:  2014-04       Impact factor: 1.973

2.  Urinary biomarkers for the early diagnosis of retinopathy and nephropathy in type 1 diabetes mellitus: a "steady stream" of information using proteomics.

Authors:  Emily K Sims; Carmella Evans-Molina
Journal:  Transl Res       Date:  2013-11-28       Impact factor: 7.012

3.  Handheld shape discrimination hyperacuity test on a mobile device for remote monitoring of visual function in maculopathy.

Authors:  Yi-Zhong Wang; Yu-Guang He; Gina Mitzel; Song Zhang; Mike Bartlett
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-08-13       Impact factor: 4.799

4.  Patient Attitudes Toward Telemedicine for Diabetic Retinopathy.

Authors:  Nita G Valikodath; Thellea K Leveque; Sophia Y Wang; Paul P Lee; Paula Anne Newman-Casey; Sean O Hansen; Maria A Woodward
Journal:  Telemed J E Health       Date:  2016-06-23       Impact factor: 3.536

5.  Improving Accuracy of Grading and Referral of Diabetic Macular Edema Using Location and Extent of Hard Exudates in Retinal Photography.

Authors:  Taras V Litvin; Camille R Weissenberg; Lauren P Daskivich; Qienyuan Zhou; George H Bresnick; Jorge A Cuadros
Journal:  J Diabetes Sci Technol       Date:  2015-11-17

Review 6.  Telemedicine for detecting diabetic retinopathy: a systematic review and meta-analysis.

Authors:  Lili Shi; Huiqun Wu; Jiancheng Dong; Kui Jiang; Xiting Lu; Jian Shi
Journal:  Br J Ophthalmol       Date:  2015-01-06       Impact factor: 4.638

7.  Dilated eye examination screening guideline compliance among patients with diabetes without a diabetic retinopathy diagnosis: the role of geographic access.

Authors:  David J Lee; Naresh Kumar; William J Feuer; Chiu-Fang Chou; Potyra R Rosa; Joyce C Schiffman; Alexis Morante; Adam Aldahan; Patrick Staropoli; Cristina A Fernandez; Stacey L Tannenbaum; Byron L Lam
Journal:  BMJ Open Diabetes Res Care       Date:  2014-08-23

8.  Assessment of Annual Diabetic Eye Examination Using Telemedicine Technology Among Underserved Patients in Primary Care Setting.

Authors:  Elham Hatef; Miriam Alexander; Bruce G Vanderver; Peter Fagan; Michael Albert
Journal:  Middle East Afr J Ophthalmol       Date:  2017 Oct-Dec

9.  Diabetic retinopathy screening and management in India: Challenges and possible solutions.

Authors:  Atul Kumar; Divya Agarwal; Aman Kumar
Journal:  Indian J Ophthalmol       Date:  2021-03       Impact factor: 1.848

10.  Diabetic Retinopathy Screening and Monitoring of Early Stage Disease in Australian General Practice: Tackling Preventable Blindness within a Chronic Care Model.

Authors:  Lisa Crossland; Deborah Askew; Robert Ware; Peter Cranstoun; Paul Mitchell; Andrew Bryett; Claire Jackson
Journal:  J Diabetes Res       Date:  2015-12-20       Impact factor: 4.011

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.